Brighteye Ventures Closes $72M First Close of Fund III

TL;DR

Brighteye Ventures, the European early-stage firm that started life as one of the continent's dedicated edtech investors, has closed a $72 million (about €62.4 million) first close of Fund III, on its way to a targeted €100 million ($115 million) final close expected in the first half of 2027. The raise pushes Brighteye's total assets under management to $245 million across three funds. It matters because Brighteye is using this fund to formally widen its mandate beyond edtech into what the firm calls "HumanOS", the broader layer of technology that helps people learn, work and adapt as AI reshapes what human capability actually means, backed by a mix of returning EIF and foundation money alongside new LPs entering venture for the first time.

Key Takeaways

Brighteye is repositioning from an edtech specialist to a "future of work and learning" generalist. Founded in 2017 as a dedicated edtech fund, the firm is using Fund III to explicitly rebrand its thesis as "HumanOS", spanning AI-augmented learning, productivity tooling for high-stakes environments, and managed labor platforms. That is a meaningful widening of mandate for a firm that built its brand and track record specifically on education technology.

New LP types signal the widened thesis is resonating outside traditional edtech circles. Lumina Foundation (a major US education-focused foundation) and Zanichelli (an Italian education publisher) are logical fits for an edtech-rooted fund, but PI Impact's participation alongside a stated focus on healthcare, cybersecurity and climate suggests LPs are underwriting Brighteye's broader "human capability" thesis, not just its education roots.

A structured "blink" check alongside core checks is a deliberate way to stay in idea-stage deal flow. With 90%-plus of the fund allocated to $0.5 million to $4 million core checks and a smaller reserved pool for $150,000 to $500,000 "blink" investments at the idea stage, Brighteye has built an explicit mechanism to keep writing very early checks without diluting the fund's primary check-size discipline.

The fund is still mid-raise, with a real gap between first and final close. A $72 million first close against a €100 million target, with final close not expected until H1 2027, means roughly a third of the fund's target capital is still to be raised. LPs and founders should treat the current headline number as a floor, not the fund's eventual size.

Fund Overview

Fund Name: Brighteye Ventures Fund III
Fund Size: $72 million (~€62.4 million) at first close; targeting €100 million (~$115 million) at final close, expected H1 2027
Stage: Early-stage (pre-seed and seed), with roughly 35 total investments expected from the fund
Check Size: $0.5 million to $4 million for core checks (90%+ of the fund); $150,000 to $500,000 "blink" checks for idea-stage bets
Geography: Europe, with Brighteye's own offices in London and Paris
Focus: "HumanOS" — technology that expands human learning, work and capability in the AI era, spanning AI-augmented learning platforms, productivity and intelligence tools for high-stakes sectors (healthcare, education, infrastructure, cybersecurity, climate), and managed labor/talent platforms
Key LPs: New: Lumina Foundation, Zanichelli, PI Impact. Returning: European Investment Fund (EIF), Jacobs Foundation, and European family offices

Why This Fund Matters

Brighteye's founding thesis in 2017, that education technology was an underinvested category deserving of a dedicated European specialist fund, was a genuinely contrarian bet at the time. Eight years and, per the firm's own figures, more than 50 investments and $1 billion-plus of aggregate follow-on capital raised by its portfolio later, that specialist positioning has become crowded as generalist funds piled into edtech during and after the pandemic. Fund III's HumanOS reframing looks like Brighteye's answer to that crowding: rather than compete for the same edtech deals as a growing list of generalist entrants, the firm is widening its aperture to the broader category of technology that makes people more capable, a thesis roomy enough to include health-system intelligence tools (NEX Health Intelligence) and blue-collar labor marketplaces (Gyver) alongside more traditional learning platforms.

The framing is also a direct response to the anxiety running through venture right now about AI and human labor. Founding partner Ben Wirz's stated thesis, that "the defining opportunity of the AI era is not replacing humans with machines, it is expanding what humans can do with machines," is as much a positioning statement for LPs nervous about AI's effect on employment and skills as it is an investment thesis. Whether that framing holds up as a genuinely differentiated filter for deal selection, rather than a rebrand applied after the fact to a fund that would have made similar investments anyway, is the open question the portfolio will answer over the next several years.

The LP base tells its own story about how specialist, mission-adjacent capital moves. Lumina Foundation and Zanichelli are natural extensions of Brighteye's existing education-sector relationships; the EIF and Jacobs Foundation returning as LPs across multiple funds is a strong repeat-LP signal that is harder to manufacture than a single splashy new name. PI Impact's participation, alongside the fund's stated interest in healthcare, cybersecurity and climate, suggests Brighteye is successfully pulling impact-oriented capital into a thesis that is broader than education alone.

Structurally, the 90/10 split between core checks and smaller "blink" idea-stage checks is a sensible way for an increasingly established fund to stay close to the earliest, highest-conviction bets without turning the whole fund into a spray-and-pray seed vehicle. It is the kind of mechanism funds tend to formalize once they have enough repeat-founder relationships and inbound deal flow that informal angel-style side bets need a real budget and process behind them.

The Team

Brighteye was co-founded by Ben Wirz and Alex Latsis, who remain the fund's two founding partners. Fund III comes with a round of internal promotions that reflect the firm's maturation: David Guérin has been promoted to partner, Isabella Vahdati to principal, and Rhys Spence to head of platform and research. Rounding out the team are Hege Tollerud as head of community and events, Andreas Schropfer as head of finance, and James Wilson as designer-in-residence. Brighteye also maintains a network of more than 20 named mentors across specialties including product, operations, learning design and international expansion, though those individuals are advisors to portfolio companies rather than investing partners at the firm.

Early Portfolio

Fund III has made eight investments to date, with three disclosed publicly: imagi, an AI-fluency platform for schools that has struck curriculum partnerships with app developers including Lovable; NEX Health Intelligence, an augmented-intelligence platform for hospital infection control; and Gyver, a B2B electrician marketplace in Italy. The remaining investments span additional European markets that the firm has not yet named publicly. Brighteye's broader firm-level portfolio, spanning all three funds, includes Zen Educate, Ornikar, Shakers and Installer, and the firm says its portfolio companies have collectively raised more than $1 billion in follow-on capital, with several now generating more than $100 million in annual revenue.

What This Means for Founders

For European pre-seed and seed founders building anything that plausibly expands human learning, work capability or adaptability in the AI era, not just narrowly-defined edtech, Brighteye's widened HumanOS mandate makes it a broader-fit investor than its historical brand suggests. The firm's explicit interest in high-stakes sectors like healthcare, cybersecurity and climate, alongside its education roots, means founders in those categories with a genuine "human capability" angle should not rule the fund out just because it built its name in edtech.

The dual check structure is also worth founders' attention directly: teams too early for a typical $0.5 million-plus seed check but with a genuinely compelling idea-stage bet have a real path to a smaller "blink" check from Brighteye, rather than needing to wait until they can absorb a full core investment.

Fund Momentum Take

We think the HumanOS repositioning is a smart, if not entirely risk-free, move. Pure-play edtech investing has gotten crowded and, in public and late-stage markets, has had a mixed few years; broadening the mandate to the wider category of AI-era human capability gives Brighteye access to a larger and arguably more durable opportunity set, and the early portfolio picks (a hospital infection-control tool, a blue-collar labor marketplace) show the firm is genuinely willing to invest outside classic edtech rather than just relabeling the same kind of deals.

The risk is thesis dilution. "Technology that expands human capability" is broad enough to describe an enormous share of venture-fundable companies, and funds that widen their stated mandate after building a track record in a narrower category sometimes struggle to maintain the same selection discipline once the aperture opens. Brighteye's advantage here is real specificity underneath the broad framing, its named focus sectors (healthcare, education, infrastructure, cybersecurity, climate) and its structured check sizes give the thesis actual boundaries rather than just marketing language. Our bet is that the repeat EIF and Jacobs Foundation LP relationships, plus the team's eight-year track record actually picking and supporting founders rather than just theorizing about them, give Brighteye a real shot at making HumanOS a durable second act rather than a rebrand in search of a thesis. The fund still has roughly a third of its target left to raise before final close, so watch for how the remaining LP base rounds out over the next several quarters.

Frequently Asked Questions

How much has Brighteye Ventures raised for Fund III?
A $72 million (about €62.4 million) first close, with a target of €100 million ($115 million) at final close, expected in the first half of 2027.

What is Brighteye's "HumanOS" thesis?
A widened investment mandate beyond traditional edtech, focused on technology that expands human learning, work and adaptability in the AI era, spanning learning platforms, productivity and intelligence tools for high-stakes sectors, and managed labor platforms.

What check sizes does Brighteye write?
Core checks of $0.5 million to $4 million make up more than 90% of the fund, alongside smaller $150,000 to $500,000 "blink" checks for idea-stage investments.

Who leads Brighteye Ventures?
Founding partners Ben Wirz and Alex Latsis lead the firm, with David Guérin recently promoted to partner alongside Fund III's close.

What has Fund III invested in so far?
Eight investments to date, including publicly disclosed bets on imagi (AI fluency for schools), NEX Health Intelligence (hospital infection-control intelligence) and Gyver (a B2B electrician marketplace in Italy).

---

Have a fund closing to announce? Submit your fund here.

Need help raising capital? Check out our Fundraising Advisory services.